المؤلفون: Chikako Funasaka, Yoichi Naito, Shota Kusuhara, Takehiro Nakao, Yoko Fukasawa, Kanako Mamishin, Ayumi Komuro, Mashiro Okunaka, Chihiro Kondoh, Kenichi Harano, Takahiro Kogawa, Nobuaki Matsubara, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara

المصدر: Breast, Vol 58, Iss , Pp 50-56 (2021)

مصطلحات موضوعية: Breast cancer, Visceral crisis, Chemotherapy, Paclitaxel plus bevacizumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S0960977621003532; https://doaj.org/toc/1532-3080

URL الوصول: https://doaj.org/article/1ee0cb78f98046edb5ecc170618af845

المؤلفون: Takahiro Kogawa, Ako Hosono, Kenichi Harano, Ayumi Komuro, Yoichi Naito, Chihiro Kondoh, Kanako Mamishin, Shota Kusuhara, Chikako Funasaka, Toru Mukohara, Takehiro Nakao, Mashiro Okunaka, Toshikatsu Kawasaki, Yoko Fukasawa, Nobuaki Matsubara

المصدر: The Breast : Official Journal of the European Society of Mastology
Breast, Vol 58, Iss, Pp 50-56 (2021)

مصطلحات موضوعية: MBC, metastatic breast cancer, Receptor, ErbB-2, medicine.medical_treatment, AST, aspartate aminotransferase, Gastroenterology, TTF, time to treatment failure, ORR, objective response rate, chemistry.chemical_compound, Paclitaxel plus bevacizumab, 0302 clinical medicine, Breast cancer, Antineoplastic Combined Chemotherapy Protocols, HER2, human epidermal growth factor receptor 2, 030212 general & internal medicine, wPTX, weekly paclitaxel, Lymphangiomatosis, RC254-282, LDH, lactate dehydrogenase, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, Metastatic breast cancer, PS, performance status, Bevacizumab, Treatment Outcome, Paclitaxel, 030220 oncology & carcinogenesis, Female, Original Article, medicine.symptom, AE, adverse event, medicine.drug, DCR, disease control rate, medicine.medical_specialty, Vena Cava, Superior, Breast Neoplasms, SVC, superior vena cava, OS, overall survival, 03 medical and health sciences, Internal medicine, ALT, alanine aminotransferase, medicine, Humans, Chemotherapy, Adverse effect, Retrospective Studies, business.industry, Organ dysfunction, Visceral crisis, BV, bevacizumab, medicine.disease, chemistry, Surgery, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceeb2f8c28b19a71d25194b192d9cf8f
https://pubmed.ncbi.nlm.nih.gov/33901922

المؤلفون: Monia Ezzalfani (7846709), Raphaël Porcher (3143676), Alexia Savignoni (340020), Suzette Delaloge (805610), Thomas Filleron (2183932), Mathieu Robain (775843), David Pérol (696205)

مصطلحات موضوعية: Cell Biology, Biotechnology, Evolutionary Biology, Cancer, Science Policy, Infectious Diseases, Virology, Mathematical Sciences not elsewhere classified, retrospective epidemiological strategy, many methods rely, compared overall survival, superficial &# 8221, pseudo &# 8221, factors initially used, using instrumental variables, paclitaxel plus bevacizumab, instrumental variables, &# 8220, major factors, %22">xlink ">, unmeasured confounders, treatment variable, treatment preference, study based, significantly longer, randomized trial, randomization trial, potential shortcomings, paclitaxel alone, multicenter trial

Relation: https://figshare.com/articles/dataset/Imbalance_between_measured_covariates_and_IV1_/16623419

الاتاحة: https://doi.org/10.1371/journal.pone.0255017.t001

المؤلفون: Monia Ezzalfani (7846709), Raphaël Porcher (3143676), Alexia Savignoni (340020), Suzette Delaloge (805610), Thomas Filleron (2183932), Mathieu Robain (775843), David Pérol (696205)

مصطلحات موضوعية: Cell Biology, Biotechnology, Evolutionary Biology, Cancer, Science Policy, Infectious Diseases, Virology, Mathematical Sciences not elsewhere classified, retrospective epidemiological strategy, many methods rely, compared overall survival, superficial &# 8221, pseudo &# 8221, factors initially used, using instrumental variables, paclitaxel plus bevacizumab, instrumental variables, &# 8220, major factors, %22">xlink ">, unmeasured confounders, treatment variable, treatment preference, study based, significantly longer, randomized trial, randomization trial, potential shortcomings, paclitaxel alone, multicenter trial

Relation: https://figshare.com/articles/figure/Assumptions_of_Instrument_variable_/16623416

الاتاحة: https://doi.org/10.1371/journal.pone.0255017.g001

المؤلفون: Monia Ezzalfani (7846709), Raphaël Porcher (3143676), Alexia Savignoni (340020), Suzette Delaloge (805610), Thomas Filleron (2183932), Mathieu Robain (775843), David Pérol (696205)

مصطلحات موضوعية: Cell Biology, Biotechnology, Evolutionary Biology, Cancer, Science Policy, Infectious Diseases, Virology, Mathematical Sciences not elsewhere classified, retrospective epidemiological strategy, many methods rely, compared overall survival, superficial &# 8221, pseudo &# 8221, factors initially used, using instrumental variables, paclitaxel plus bevacizumab, instrumental variables, &# 8220, major factors, %22">xlink ">, unmeasured confounders, treatment variable, treatment preference, study based, significantly longer, randomized trial, randomization trial, potential shortcomings, paclitaxel alone, multicenter trial

Relation: https://figshare.com/articles/dataset/Median_survival_and_HR_for_centers_grouped_by_of_patients_treated_/16623422

الاتاحة: https://doi.org/10.1371/journal.pone.0255017.t002

المؤلفون: Monia Ezzalfani (7846709), Raphaël Porcher (3143676), Alexia Savignoni (340020), Suzette Delaloge (805610), Thomas Filleron (2183932), Mathieu Robain (775843), David Pérol (696205)

مصطلحات موضوعية: Cell Biology, Biotechnology, Evolutionary Biology, Cancer, Science Policy, Infectious Diseases, Virology, Mathematical Sciences not elsewhere classified, retrospective epidemiological strategy, many methods rely, compared overall survival, superficial &# 8221, pseudo &# 8221, factors initially used, using instrumental variables, paclitaxel plus bevacizumab, instrumental variables, &# 8220, major factors, %22">xlink ">, unmeasured confounders, treatment variable, treatment preference, study based, significantly longer, randomized trial, randomization trial, potential shortcomings, paclitaxel alone, multicenter trial

Relation: https://figshare.com/articles/dataset/OS_HR_and_95_CI_for_the_different_approaches_using_Beva_PAcli_database_/16623425

الاتاحة: https://doi.org/10.1371/journal.pone.0255017.t003

المؤلفون: Loges, Sonja, Mazzone, Max, Hohensinner, Philipp, Carmeliet, Peter

مصطلحات موضوعية: endothelial growth-factor, paclitaxel plus bevacizumab, renal-cell carcinoma, tumor angiogenesis, colorectal-cancer, breast-cancer, irinotecan, efficacy, receptor, therapy, Angiogenesis Inhibitors, Animals, Drug Resistance, Neoplasm, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Vascular Endothelial Growth Factor A

Relation: Cancer Cell vol:15 issue:3 pages:167-170; https://lirias.kuleuven.be/handle/123456789/229191; http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DOISource&SrcApp=PRODUCT_NAME&KeyAID=10.1016%2Fj.ccr.2009.02.007&DestApp=DOI&SrcAppSID=APP_SID&SrcJTitle=WURS_TITLE; http://linkinghub.elsevier.com/retrieve/pii/S1535-6108(09)00040-3

الاتاحة: https://lirias.kuleuven.be/handle/123456789/229191
http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DOISource&SrcApp=PRODUCT_NAME&KeyAID=10.1016%2Fj.ccr.2009.02.007&DestApp=DOI&SrcAppSID=APP_SID&SrcJTitle=WURS_TITLE
http://linkinghub.elsevier.com/retrieve/pii/S1535-6108(09)00040-3